Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategies
about
Immune Checkpoint Blockade: A New Paradigm in Treating Advanced CancerMiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathwayFolate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migrationDrug resistance to molecular targeted therapy and its consequences for treatment decisions in non-small-cell lung cancer.Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1).Insulin-like Growth Factor 1 Receptor Expression in Advanced Non-small-cell Lung Cancer and its Impact on Overall Survival.Overexpression of microRNA-133b sensitizes non-small cell lung cancer cells to irradiation through the inhibition of glycolysis.Apigenin in cancer therapy: anti-cancer effects and mechanisms of action.Small interfering RNA targeting S100A4 sensitizes non-small-cell lung cancer cells (A549) to radiation treatment.Cell death-based treatment of lung adenocarcinoma.Ambroxol enhances anti-cancer effect of microtubule-stabilizing drug to lung carcinoma through blocking autophagic flux in lysosome-dependent way.Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients.
P2860
Q26795509-3E5FEB3A-7CA5-45E6-8117-2982FF5908F4Q28534731-DF67DA69-C267-4043-9847-D68C75481830Q28829561-E7D8E310-EA19-41E7-BF51-1D81DCA0C7FBQ33938441-1D315A98-5A14-42A9-A87F-986687EA6272Q35860664-120EEB49-65CC-401E-910B-0EE7460FCCCFQ38663388-DD8F1E78-3682-4D66-A67F-2D242620EEFAQ39642743-1F8964F8-4170-47D9-98E3-AD4AFAF94D31Q42371219-9B467F45-AEF3-43AE-82E8-2C803FBF57F8Q42532886-FAB72386-E298-4DCA-B5E3-6FB1DD76CF3AQ47711273-40BC1604-D938-49CE-8A3B-53880215F59AQ48546255-33147FCC-80DF-46AA-A4EC-EF4343C8666FQ54114243-9169DEB0-9FAA-496B-8419-33CF24ACC7E3
P2860
Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategies
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Non-small-cell lung cancer: mo ...... ce, mechanisms, and strategies
@en
type
label
Non-small-cell lung cancer: mo ...... ce, mechanisms, and strategies
@en
prefLabel
Non-small-cell lung cancer: mo ...... ce, mechanisms, and strategies
@en
P2093
P2860
P356
P1476
Non-small-cell lung cancer: mo ...... ce, mechanisms, and strategies
@en
P2093
Amber D Cizmic
Christine Brzezinski
Marybeth Sechler
Michelle Van Scoyk
Nicole Kelley
Rama Kamesh Bikkavilli
Robert A Winn
Sreedevi Avasarala
P2860
P356
10.2147/PGPM.S26058
P577
2013-04-04T00:00:00Z